British Thoracic Society Endorses Buteyko
May 2008 the updated British Guidelines for the Management of Asthma endorsed Buteyko Technique so that GPs and asthma nurses can now recommend it. The new guidelines grade the research on Buteyko as a 'B' classification - indicating that there are high quality clinical trials supporting the efficacy of the therapy in reducing both asthma symptoms and bronchiodilator usage. No other complementary therapy has been endorsed by this body for the treatment of asthma. The guidelines are produced jointly by the Scottish Intercollegiate Guidelines Network and the British Thoracic Society.
"The Buteyko breathing technique specifically focuses on control of hyperventilation and any ensuing hypocapnia. Four clinical trials suggest benefits in terms of reduced symptoms and
bronchodilator usage but no effect on lung function.261-264. Buteyko breathing technique may be considered to help patients to control the symptoms of asthma."
The Lancet, Volume 368, Number 9537, 26 August 2006
A plea to abandon asthma as a disease concept
We dedicate almost all of this week's issue to asthma one of the most elusive of all common chronic disorders. An estimated 300 million people live with asthma worldwide; this is expected to increase to 400 million by 2025. Morbidity and mortality are high despite treatment that is effective in the majority of patients. Asthma deaths are estimated to account for one in 250 deaths worldwide, and even in developed countries where patients have easy access to treatment, asthma is often under-recognised and undertreated with sometimes fatal consequences.
There has been particular concern about an increase in prevalence, especially of childhood asthma, in the past two decades, most apparent in countries that have or are developing a western lifestyle. Epidemiological studies, as well as some preliminary basic research, have given rise to the hygiene hypothesis. The idea is that in cleaner environments with fewer infections and stimuli to the immature immune system in early childhood, there is an aberrant inflammatory response to allergens and other environmental irritants. In the ISAAC Phase Three study, which was designed to look at worldwide time trends of asthma, allergic rhinoconjunctivits, and eczema in children aged 6-7 and 13-14 years, the picture is not entirely clear-cut. Overall, increases rather than decreases in prevalence were more common over the past decade, and occurred more often in the younger age group (more pronounced in rhinoconjunctivits and eczema). However, asthma rates in high-prevalence countries decreased slightly in children aged 13/14 years. This study's findings are indicative of much of asthma research and epidemiology. The harder one looks, the more questions arise.
The general consensus now emerging is that, even in adults, asthma is unlikely to be a single disease entity.
So why wait?
Rather than confusing scientists, doctors, and patients even further, is it not time to step out of the straightjacket of a seemingly unifying name that has outlived its usefulness? The conclusion should surely be that it is best to abolish the term asthma altogether.Comments on this article:
Asthma, a disease of chronic hyperventilation.
Michael Lingard, August 30 2006
Professor Konstantin Buteyko suggested asthma is a single disease with multiple triggers, rather than a complex disease with multiple causes. He also found a high correlation between chronic hyperventilation and asthma symptoms. Anecdotal evidence from asthma sufferers using the Buteyko Method to reduced their hyperventilation suggests this approach is effective for all asthmatics. This observation was supported by a papers by Bowler et alia1 ,Cooper S, Osborne J, Newton S, Harrison V, Thompson-Coon, et alia 2 and McHugh P, Aitcheson F, Duncan B, Houghton F 3. The dramatic reduction in the medication needed to manage asthma in the few trials so far conducted has been encountered by two UK doctors who sent a number of their asthma patients on Buteyko Courses and have since been able to save thousands of pounds on their drug bills whilst their patients have enjoyed better health with less medication.4
The Buteyko Method usually is taught to small groups of 5-10 people at sessions of 90 minutes over five consecutive days.
Patients are taught:
a. The importance of nose breathing.
b. A simple nose clearing exercise requiring only a comfortable breath hold.
c. How to measure chronic hyperventilation based on comfortable breath hold time. This relies on the observation that hyperventilators have to breathe more to achieve a lower Pa CO2, and therefore, have less breath holding ability.
d. How to reverse chronic hyperventilation by deliberately reducing breathing through relaxation of respiratory muscles and achieving a feeling of slight shortage of air over time. (Through resetting of the respiratory centres to normal CO2 levels.)
e. Lifestyle changes that will help reduce over breathing. These are generally recognised as promoting health and include recommendations such as eating less and performing more non-stressful exercise.
f. Practical, safe and effective advice for keeping the mouth closed at all times, to avoid mouth breathing.
Radio interview - part 1
Radio interview - part 2
